AventaCell BioMedical Corp. is among the world leaders in developing human platelet lysate for cell culture and tissue regeneration. AventaCell technologies offer new human-derived solutions for cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production in research and clinical applications.